Literature DB >> 24941208

Fluoxetine treatment of selective mutism in pervasive developmental disorder.

Raza Silveira1, Ashok Kumar Jainer, Gordon Bates.   

Abstract

We report the successful treatment of selective mutism in a child with pervasive developmental disorder (PDD). There are several studies and case reports in which Fluoxetine has been reported effective in diminishing adult social anxiety and increasing speech in public settings. The literature is much smaller for children. The efficacy of fluoxetine supports the argument that selective mutism is a developmental equivalent of social anxiety disorder. To our knowledge this is the first description of successful treatment when the selective mutism is complicated by PDD.

Entities:  

Keywords:  fluoxetine; pervasive developmental disorder (PDD); selective mutism; social anxiety

Year:  2004        PMID: 24941208     DOI: 10.1080/13651500410006143

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  2 in total

Review 1.  The use of medication in selective mutism: a systematic review.

Authors:  Katharina Manassis; Beate Oerbeck; Kristin Romvig Overgaard
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-11-09       Impact factor: 4.785

Review 2.  Anxiety in children and adolescents with autism spectrum disorders.

Authors:  Susan W White; Donald Oswald; Thomas Ollendick; Lawrence Scahill
Journal:  Clin Psychol Rev       Date:  2009-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.